The Latest

clinical trial

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.
street entrance to the building containing the HIV clinic at Zuckerberg San Francisco General Hospital and Trauma Center

This San Francisco Clinic Is Rethinking Care for People Living With HIV Experiencing Homelessness

The results: 79% of enrolled participants restarted their antiretroviral therapy within a week of enrolling, and 55% were virally suppressed after six months.

By Larry Buhl
part of the poster exhibition area during CROI 2018

Major Conference on HIV and COVID-19 Under Fire for Putting Science Behind Paywall

For the first time, the influential annual CROI was going to postpone making its ample data available to the public. But the global HIV community swiftly protested.

By Tim Murphy
Stephaun Wallace, Ph.D., M.S., and Raniyah Copeland

“It’s About Our Community”: Newly Formed Science Initiative Aims to Center the Black Experience in HIV and COVID Care

Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

By Terri Wilder, M.S.W.
building bridges

This Week in HIV Research: The Bridges We Strive to Make

Jan. 28, 2021: COVID-19 information mistrust among Black PLWH; opportunities to intervene prior to deadly drug overdoses; we're unprepared for end-of-life needs for aging PLWH; hospitalization disparities despite universal health care.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Are Our Priorities in the Right Place?

Dec. 10, 2020: Where the Ending the HIV Epidemic plan falls short; housing instability and HIV care incentives; financial wellbeing vs. health care access; San Diego's complex webs of HIV transmission.

By Barbara Jungwirth and Myles Helfand
Black doctor Black patient vaccine

4 Things We Must Do to Fight Medical Mistrust After the COVID-19 Pandemic Ends

It’s long been time to put Black experts at the center of public health, make public health visible and relatable to people, and truly understand and address medical mistrust.

By Kenyon Farrow
prescription bottle

PrEP and Prior Authorization: A Discriminatory Cheap Ploy

An important new analysis describes a key barrier to PrEP in the U.S., one that is almost sinister in its application predominantly in southern states.

By David Alain Wohl, M.D.
pregnant woman

Neighborhood Is a Factor in Women’s HIV Viral Load During Pregnancy

A reasonably understandable initial response to this important study could be “WTF”—but the forces that conspire to harm people of color and people living in poverty are persistent and intransigent.

By David Alain Wohl, M.D.
Joe Biden

Biden Wins. What’s Next for HIV Medicine?

"More than anything, I worried that the four years of his administration would not be good for people living with HIV. At the end of those four years, some of these worries have been validated."

By David Alain Wohl, M.D.